Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
2017 and all that. The 2017 ESC/EACTS Guidelines for the management of valvular heart disease1 and in particular the recommendations with regard to choice of intervention mode for the treatment of aortic stenosis, may effect more change in cardiology treatment algorithms than most original research published in 2017, marking as they do, a significant shift towards transcatheter aortic valve… View more
Author(s): Karel M Van Praet , Christof Stamm , Simon H Sündermann , et al Added: 3 years ago
For the paper entitled ‘Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review’, which appeared in Interventional Cardiology Review 2018;13(1):14–9, the source for Tables 1–2 and Figure 1 is shown as: ‘Courtesy of Professor Volkmar Falk; adapted from Baumgartner, et al., 2017’. The statement of source should be: ‘Baumgartner H, et al. 2017 ESC/EACTS Guidelines for the management… View more
Author(s): Luca Testa , Azeem Latib Added: 3 years ago
Leaflet motion abnormalities (LMAs) are a relatively new entity in the field of transcatheter aortic valves (TAVs).1–4 They can be associated with the thrombosis of the bioprosthesis (TAVT), often leading to dramatic clinical scenarios1 or, on the other hand, they can result in a hypoattenuated leaflet thickening (HALT) and/or reduced leaflet motion (RELM), both usually associated with gradients… View more
Author(s): Karel M Van Praet , Christof Stamm , Simon H Sündermann , et al Added: 3 years ago
Reconstructive valve surgery encompasses a comprehensive system of valve analysis and related techniques based on three basic principles as described by Alain Carpentier and colleagues: restoring or preserving the full mobility of the leaflets, creating a large surface of leaflet coaptation and remodelling the annulus to provide an optimal and stable orifice area.1 Mitral valve regurgitation (MR)… View more
Author(s): Philip MacCarthy , Dave Smith , Douglas Muir , et al Added: 3 years ago
Author(s): Yusuke Watanabe , Makoto Nakashima Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has become a commonly used and minimally invasive approach for patients with severe aortic stenosis (AS).1,2 In the latest guidelines from the 2017 European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) for the management of valvular heart disease, the following clinical characteristics favour TAVI: Society of… View more
Author(s): Magdalena Erlebach , Ruediger Lange Added: 3 years ago
Patients with multivalvular disease (MVD) can present with a variety of valve pathologies and combinations, often requiring a complex treatment strategy. Both the Euro Heart Survey and the EURObservational Research Programme Valvular Heart Disease Registry (presented at the European Society of Cardiology [ESC] 2018 meeting) demonstrated that more than one-fifth of patients with native valve… View more
Author(s): Chiara Fraccaro , Noemie Tence , Giulia Masiero , et al Added: 3 years ago
Valvular heart disease (VHD) is encountered in approximately 1% of pregnancies, significantly increasing both maternal and foetal risk.1,2 Rheumatic VHD remains the most common form in non-Western countries, whereas congenital heart disease dominates in the Western world.3,4 As increasing numbers of women with congenital heart disease are reaching childbearing age, the prevalence of women of… View more